Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection

Journal:
Science Translational Medicine
Published:
DOI:
10.1126/scitranslmed.adv4214
Affiliations:
31
Authors:
36
Institutions Authors Share
Fukushima Medical University (FMU), Japan
7.750000
0.22
Nagoya University, Japan
5.476190
0.15
The University of Tokyo (UTokyo), Japan
4.500000
0.13
Hokkaido University, Japan
3.350000
0.09
Hirata Central Hospital, Japan
2.750000
0.08
Medical Governance Research Institute, Japan
2.250000
0.06
Nagoya University Hospital, Japan
2.000000
0.06
WPI International Research Center for Neurointelligence (WPI-IRCN), UTokyo, Japan
1.142857
0.03
National Institute of Infectious Diseases (NIID), Japan
1.000000
0.03
Chiba University, Japan
1.000000
0.03
Medical Excellence JAPAN (MEJ), Japan
1.000000
0.03
Pusan National University (PNU), South Korea
0.833333
0.02
Yokohama City University (YCU), Japan
0.500000
0.01
Medical and Biological Laboratories Co., Ltd. (MBL), Japan
0.500000
0.01
Kyushu University, Japan
0.450000
0.01
Pukyong National University (PKNU), South Korea
0.333333
0.01
Minamisoma Municipal General Hospital, Japan
0.250000
0.01
The University of Osaka (UOsaka), Japan
0.200000
0.01
Kyoto University, Japan
0.142857
0.00
WPI Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Japan
0.142857
0.00
RIKEN Interdisciplinary Theoretical and Mathematical Sciences Program (iTHEMS), Japan
0.142857
0.00
Japanese Foundation for Cancer Research (JFCR), Japan
0.142857
0.00
Science Groove, Inc., Japan
0.142857
0.00
AMED-CREST, Japan
0.000000
0.00